Home / Comparisons / XBI vs IBB

XBI vs IBB: ETF Comparison Notes

Use this page to compare SPDR S&P Biotech ETF and iShares Biotechnology ETF through structure, exposure, costs, overlap questions, and risk fit.

Last reviewed 2026-07-27ETF comparisonEducational use

Quick read: XBI is usually researched as biotech exposure, while IBB is usually researched as biotech exposure. The better question is not which fund is universally preferable, but which structure better matches the account, holding period, and diversification need.

Side-by-Side Research Table

Research angle	XBI	IBB
Fund name	SPDR S&P Biotech ETF	iShares Biotechnology ETF
Issuer	State Street	iShares
Category	industry equity	industry equity
Portfolio role	biotech exposure	biotech exposure

Questions to Ask Before Choosing

Do the two ETFs track the same market, or are they solving different allocation jobs?
How concentrated are the top holdings, and does that concentration duplicate other positions?
Are yield, tax treatment, trading spreads, and rebalancing needs important for this account?
Has the reader checked the latest prospectus, fee schedule, and issuer materials?

Portfolio Fit Notes

A broad-market fund can behave very differently from a sector, thematic, income, commodity, or crypto asset product. When two ETFs look similar at first glance, compare the index methodology, constituent rules, turnover, option overlay, bond duration, or commodity structure behind the ticker.

Sources to Check

Fund details, fees, risks, holdings, and sponsor materials change over time. Use this page as a research map, then verify current documents before making decisions.